Clinical Trial Update: A Study of ZN-c5 in Subjects With Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 clinical trial of ZN-c5 in breast cancer have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ZN-c5

Snippet

Sponsor: Zeno Alpha Inc. | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-08-09